therascreen® KRAS RGQ PCR Kit

DIAGNOSTIC_TEST8 trials

Sponsors

QIAGEN Gaithersburg, Inc, QIAGEN Manchester Limited, Hoffmann-La Roche

Conditions

Colo-rectal CancerColorectal CancerColorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma(PDAC), Non-Small Cell Lung Cancer (NSCLC), or other solid tumor Colon cancer, pancreatic cancer, lung cancer, other solid tumorsColorectal Cancer, KRAS mutant CancerLung Cancer, KRAS mutant CancerMetastatic Colorectal Cancer (mCRC)Non Small Cell Lung CancerNon-Small Cell Lung Cancer

Unknown Phase

Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit

CompletedNCT05347797

QIAGEN Gaithersburg, IncNon-small Cell Lung Cancer

Start: 2020-03-13End: 2021-04-22Updated: 2024-11-04

Therascreen® KRAS RGQ PCR Kit

CompletedNCT05347745

QIAGEN Gaithersburg, IncColo-rectal Cancer

Start: 2022-01-07End: 2023-04-30Updated: 2025-03-24

Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

CompletedNCT05348187

QIAGEN Gaithersburg, IncColorectal Cancer, Non-Small Cell Lung Cancer

Start: 2019-07-01End: 2020-11-23Updated: 2024-11-04

Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit

CompletedNCT05360225

QIAGEN Gaithersburg, IncNon Small Cell Lung Cancer

Start: 2020-04-02End: 2022-05-26Updated: 2024-11-04

DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

RecruitingNCT06645236

QIAGEN Gaithersburg, IncMetastatic Colorectal Cancer (mCRC)

Start: 2023-12-22End: 2030-10-31Target: 600Updated: 2025-08-15

RecruitingNL-OMON58259

QIAGEN Manchester LimitedColorectal Cancer, KRAS mutant Cancer

Start: 2026-05-29Target: 10Updated: 2026-08-24

Testing FFPE samples using therascreen® KRAS RGQ PCR assay to determine if patients are eligible for GO45416

Active, not recruitingNL-OMON58383

Hoffmann-La RocheColorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma(PDAC), Non-Small Cell Lung Cancer (NSCLC), or other solid tumor Colon cancer, pancreatic cancer, lung cancer, other solid tumors

Start: 2026-05-22Target: 30Updated: 2026-03-16

RecruitingNL-OMON58448

QIAGEN Manchester LimitedLung Cancer, KRAS mutant Cancer

Start: 2026-08-12Target: 8Updated: 2026-08-24